MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
8.24
0.00
0.00%
After Hours: 8.24 0 0.00% 16:52 12/18 EST
OPEN
8.56
PREV CLOSE
8.24
HIGH
8.90
LOW
8.18
VOLUME
1.04M
TURNOVER
--
52 WEEK HIGH
17.58
52 WEEK LOW
5.00
MARKET CAP
499.26M
P/E (TTM)
-1.3238
1D
5D
1M
3M
1Y
5Y
1D
Ginkgo Bioworks, Agricen enter collaboration
TipRanks · 1d ago
Weekly Report: what happened at DNA last week (1208-1212)?
Weekly Report · 3d ago
ProteoNic's 2G UNic Technology Licensed By Ginkgo Bioworks For Use In $22.2M Project Awarded To Ginkgo By Biomedical Advanced Research And Development Authority
Benzinga · 12/11 13:49
Ginkgo Bioworks partners with Deep Origin to develop new drug safety tools
TipRanks · 12/09 13:10
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
PR Newswire · 12/09 13:00
Weekly Report: what happened at DNA last week (1201-1205)?
Weekly Report · 12/08 09:35
Ginkgo Bioworks Shares Rise After 4-Year, $47M Contract
Dow Jones · 12/05 14:51
Ginkgo Bioworks Awarded 4-Yr, Up To $47M Contract By EMSL To Co-Design, Build, And Integrate High‑Throughput Automated Phenotyping Platform In Support Of M2PC
Benzinga · 12/05 13:42
More
About DNA
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatics support services, offered to both government and non-government customers through its two core offerings: Canopy and Horizon. The Company provides comprehensive research and development services spanning the genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.